27634880|t|Evidence that vitronectin is a potent migration-enhancing factor for cancer cells chaperoned by fibrinogen: a novel view of the metastasis of cancer cells to low- fibrinogen lymphatics and body cavities
27634880|a|Diluted (1%) plasma induces migration of malignant cell lines much more strongly than potent pro-metastatic factors. To characterize the factor(s) present in diluted plasma responsible for this phenomenon we performed i) heat inactivation, ii) dialysis, iii) proteinase K treatment, and iv) molecular size filtration studies. We found that this remarkable pro-migratory activity of diluted normal plasma is associated with a ~50-100-kD protein that interacts with GαI protein-coupled receptors and activates p42/44 MAPK and AKT signaling in target cells. Since this pro-migratory activity of 1% plasma decreases at higher plasma concentrations (> 20%), but is retained in serum, we hypothesized that fibrinogen may be involved as a chaperone of the protein(s). To identify the pro-migratory protein(s) present in diluted plasma and fibrinogen -depleted serum, we performed gel filtration and hydrophobic interaction chromatography followed by mass spectrometry analysis. We identified several putative protein candidates that were further tested in in vitro experiments. We found that this pro-migratory factor chaperoned by fibrinogen is vitronectin, which activates uPAR, and that this effect can be inhibited by fibrinogen. These results provide a novel mechanism for the metastasis of cancer cells to lymphatics and body cavities, in which the concentration of fibrinogen is low, and thus suggests that free vitronectin stimulates migration of tumor cells.
27634880	14	25	vitronectin	T103	UMLS:C0055023
27634880	38	64	migration-enhancing factor	T103	UMLS:C0574031
27634880	69	81	cancer cells	T017	UMLS:C0597032
27634880	82	92	chaperoned	T103	UMLS:C0243041
27634880	96	106	fibrinogen	T103	UMLS:C0016006
27634880	128	138	metastasis	T038	UMLS:C4255448
27634880	142	154	cancer cells	T017	UMLS:C0597032
27634880	163	173	fibrinogen	T103	UMLS:C0016006
27634880	174	184	lymphatics	T022	UMLS:C0024235
27634880	189	202	body cavities	T082	UMLS:C0333343
27634880	216	222	plasma	T031	UMLS:C0032105
27634880	231	240	migration	T038	UMLS:C1622501
27634880	244	264	malignant cell lines	T017	UMLS:C0334227
27634880	369	375	plasma	T031	UMLS:C0032105
27634880	462	474	proteinase K	T103	UMLS:C0059256
27634880	600	606	plasma	T031	UMLS:C0032105
27634880	639	646	protein	T103	UMLS:C0033684
27634880	667	696	GαI protein-coupled receptors	T103	UMLS:C0682972
27634880	711	722	p42/44 MAPK	T103	UMLS:C0752312
27634880	727	740	AKT signaling	T038	UMLS:C1623484
27634880	751	756	cells	T017	UMLS:C0007634
27634880	798	804	plasma	T031	UMLS:C0032105
27634880	875	880	serum	T031	UMLS:C0229671
27634880	903	913	fibrinogen	T103	UMLS:C0016006
27634880	935	944	chaperone	T103	UMLS:C0243041
27634880	952	962	protein(s)	T103	UMLS:C0033684
27634880	980	1004	pro-migratory protein(s)	T103	UMLS:C0033684
27634880	1024	1030	plasma	T031	UMLS:C0032105
27634880	1035	1045	fibrinogen	T103	UMLS:C0016006
27634880	1056	1061	serum	T031	UMLS:C0229671
27634880	1076	1090	gel filtration	T058	UMLS:C0008559
27634880	1095	1133	hydrophobic interaction chromatography	T058	UMLS:C0008550
27634880	1146	1172	mass spectrometry analysis	T058	UMLS:C0037813
27634880	1205	1212	protein	T103	UMLS:C0033684
27634880	1261	1272	experiments	T062	UMLS:C0681814
27634880	1293	1313	pro-migratory factor	T103	UMLS:C0574031
27634880	1314	1324	chaperoned	T103	UMLS:C0243041
27634880	1328	1338	fibrinogen	T103	UMLS:C0016006
27634880	1342	1353	vitronectin	T103	UMLS:C0055023
27634880	1418	1428	fibrinogen	T103	UMLS:C0016006
27634880	1478	1488	metastasis	T038	UMLS:C4255448
27634880	1492	1504	cancer cells	T017	UMLS:C0597032
27634880	1508	1518	lymphatics	T022	UMLS:C0024235
27634880	1523	1536	body cavities	T082	UMLS:C0333343
27634880	1568	1578	fibrinogen	T103	UMLS:C0016006
27634880	1615	1626	vitronectin	T103	UMLS:C0055023
27634880	1638	1647	migration	T038	UMLS:C1622501
27634880	1651	1662	tumor cells	T017	UMLS:C0597032